Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Pilot Study of Hemoporfin Photodynamic Therapy in Children (7-14 Years Old) With Port-wine Stain

Trial Profile

A Pilot Study of Hemoporfin Photodynamic Therapy in Children (7-14 Years Old) With Port-wine Stain

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2018

At a glance

  • Drugs Hematoporphyrin monomethyl ether (Primary)
  • Indications Port-wine stain
  • Focus Therapeutic Use
  • Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
  • Most Recent Events

    • 06 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 06 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
    • 12 Jun 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top